Nova Patents
AT460500T

Compositions and methods for siRNA inhibition of angiogenesis

Abstract

This record has no abstract on file.

Term

Term ended

Expired 18 July 2023, 3.2 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

53 members in 15 offices

This recordMember, by publication datePriority claim5 more offices are in the list below

Priority claims3

Priority claims
DocumentOfficeKindDate
39841702United States of AmericaP
29422802United States of AmericaA
0322444United States of AmericaW

Members53

Family members, oldest first
DocumentOfficeKind
CA2493499A1CanadaA1
US2004018176A1United States of AmericaA1
WO2004009769A2World Intellectual Property Organization (WIPO)A2
AU2003253995A1AustraliaA1
MXPA05001000AMexicoA
KR20050056944ARepublic of KoreaA
EP1578933A2European Patent Office (EPO)A2
IL166274A0IsraelA0
JP2006505251AJapanA
WO2004009769A3World Intellectual Property Organization (WIPO)A3
US7148342B2United States of AmericaB2
US2006286073A1United States of AmericaA1
US2006292120A1United States of AmericaA1
US2007003523A1United States of AmericaA1
US2007037760A1United States of AmericaA1
US2007037761A1United States of AmericaA1
US2007037762A1United States of AmericaA1
US2007149471A1United States of AmericaA1
EP1578933A4European Patent Office (EPO)A4
AU2003253995B2AustraliaB2
US7345027B2United States of AmericaB2
US2008188437A1United States of AmericaA1
US2009104259A1United States of AmericaA1
US7674895B2United States of AmericaB2
EP1578933B1European Patent Office (EPO)B1
AT460500TThis recordAustriaT
ATE460500T1AustriaT1
DE60331683D1GermanyD1
IL166274AIsraelA
EP2192187A2European Patent Office (EPO)A2
ES2340843T3SpainT3
PT1578933EPortugalE
US2010168207A1United States of AmericaA1
US7750143B2United States of AmericaB2
DK1578933T3DenmarkT3
EP2192187A3European Patent Office (EPO)A3
NZ537833ANew ZealandA
EP1578933B9European Patent Office (EPO)B9
KR20110063597ARepublic of KoreaA
EP2345718A2European Patent Office (EPO)A2
IL196798A0IsraelA0
EP2345718A3European Patent Office (EPO)A3
IL196798AIsraelA
EP2192187B1European Patent Office (EPO)B1
KR101280269B1Republic of KoreaB1
US8541384B2United States of AmericaB2
US8546345B2United States of AmericaB2
JP5337337B2JapanB2
US2014056969A1United States of AmericaA1
US8946403B2United States of AmericaB2
US2015110861A1United States of AmericaA1
US9150863B2United States of AmericaB2
CA2493499CCanadaC